Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-26-025920
Filing Date
2026-03-11
Accepted
2026-03-11 06:40:18
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 12462
2 LETTER TO THE BOARD OF DIRECTORS OF ISSUER ea028037501ex-a.htm EX-99.A 31808
3 TRANSACTIONS COMPLETED BY REPORTING PERSONS IN THE COMMON STOCK ea028037501ex-b.htm EX-99.B 10123
4 GRAPHIC ea028037501_ex-aimg1.jpg GRAPHIC 3083
  Complete submission text file 0001213900-26-025920.txt   60537
Mailing Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720
Business Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720 (978) 631-0152
Bluejay Diagnostics, Inc. (Subject) CIK: 0001704287 (see all company filings)

EIN.: 473552922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-93056 | Film No.: 26741495
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 120 NEWPORT CENTER DR STE 250 NEWPORT BEACH CA 926660
Business Address 120 NEWPORT CENTER DR STE 250 NEWPORT BEACH CA 926660 9498757003
NORTHSTRIVE FUND II LP (Filed by) CIK: 0002099270 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D